Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Boris Gershman, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Liu Y, Zhao YC, Lu Y, Goodarz D, Gershman B. The role of smoking in explaining racial/ethnic disparities in bladder cancer incidence in the United States. Urol Oncol. 2023 Feb 25. PMID: 36849327.
    Citations:    Fields:    
  2. Morton E, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim SP, Bellmunt J, Kaplan I, Olumi AF, Gershman B. Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection. Urol Oncol. 2022 Dec 02. PMID: 36470805.
    Citations:    Fields:    
  3. Estevez A, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Bellmunt J, Olumi AF, Rayala H, Gershman B. Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer. Urol Oncol. 2022 Nov 28. PMID: 36456453.
    Citations:    Fields:    
  4. Schaufler C, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim S, Bellmunt J, Kaplan I, Olumi AF, Gershman B. Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy. Prostate Cancer Prostatic Dis. 2022 Nov 25. PMID: 36434164.
    Citations:    Fields:    
  5. Gershman B. Witchcraft beliefs around the world: An exploratory analysis. PLoS One. 2022; 17(11):e0276872. PMID: 36417350; PMCID: PMC9683553.
    Citations: 1     Fields:    Translation:Humans
  6. Ramos F, Korets R, Fleishman A, Kaul S, Johnson M, Wei JL, Olumi AF, Tsai LL, Gershman B. Comparative Effectiveness of Magnetic Resonance Imaging-Ultrasound Fusion Versus In-bore Magnetic Resonance Imaging-targeted Prostate Biopsy. Urology. 2023 01; 171:164-171. PMID: 36206828.
    Citations:    Fields:    Translation:Humans
  7. Moshnikova A, Golijanin B, Amin A, Doyle J, Kott O, Gershman B, DuPont M, Li Y, Lu X, Engelman DM, Andreev OA, Reshetnyak YK, Golijanin D. Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin. Front Urol. 2022; 2. PMID: 36439552; PMCID: PMC9691284.
    Citations:    
  8. Morrison JC, Sax-Bolder A, Gershman B, Konety B, Clark PE, Gonzalez CM, Bronsert MR, Lloyd G, Pessoa RR, Ballon-Landa E, Kim SP. Geographic Variation of Infectious Complications Following Prostate Biopsy in The United States: Results From a Population-Based Cohort of Privately Insured Patients. Urology. 2022 10; 168:27-34. PMID: 35809698.
    Citations:    Fields:    Translation:Humans
  9. Bharadwaj M, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, Kim S, Bellmunt J, Kaplan I, Olumi AF, Gershman B. Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder. Urol Oncol. 2022 06; 40(6):274.e15-274.e23. PMID: 35307291.
    Citations:    Fields:    Translation:Humans
  10. Liu S, Wang Z, Long X, Fleishman A, Huang X, Wu Q, Gershman B, Olumi AF. Single black men have the worst prognosis with localized prostate cancer. Can J Urol. 2022 02; 29(1):10992-11002. PMID: 35150221.
    Citations:    Fields:    Translation:Humans
  11. Softness K, Kaul S, Fleishman A, Efstathiou J, Bellmunt J, Kim SP, Korets R, Chang P, Wagner A, Olumi AF, Gershman B. Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladder. Urol Oncol. 2022 06; 40(6):272.e1-272.e9. PMID: 35058142.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  12. Sharkey C, Long X, Wang Z, Al-Faouri R, Gershman B, Tsai LL, Olumi AF. Zonal Growth Pattern of the Prostate Is Affected by Age and Body Mass Index. J Urol. 2022 04; 207(4):876-884. PMID: 34854747.
    Citations:    Fields:    Translation:Humans
  13. Cahill LC, Rosen S, Yoshitake T, Wu Y, York L, Tsai LL, Gershman B, Fujimoto JG, Sun Y. Real-time diagnosis and Gleason grading of prostate core needle biopsies using nonlinear microscopy. Mod Pathol. 2022 04; 35(4):539-548. PMID: 34725447; PMCID: PMC8560363.
    Citations: 1     Fields:    Translation:Humans
  14. Nathan A, Gershman B, Van der Poel H, Sooriakumaran P. Centralisation of Care for Prevalent Urological Malignancies: The Case for Prostate Cancer. Eur Urol Focus. 2021 09; 7(5):920-923. PMID: 34531115.
    Citations:    Fields:    Translation:Humans
  15. Monfared S, Fleishman A, Korets R, Chang P, Wagner A, Bubley G, Kaplan I, Olumi AF, Gershman B. The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillance. Urol Oncol. 2021 11; 39(11):783.e21-783.e30. PMID: 33992521.
    Citations: 1     Fields:    Translation:Humans
  16. Reitblat C, Fleishman A, Kaplan IA, Stensland KD, D'Amico AV, Olumi AF, Wagner AA, Chang PK, Kim SP, Korets R, Gershman B. Radical prostatectomy versus external beam radiation therapy for high-grade, clinically localized prostate cancer: Emulation of a target clinical trial. Urol Oncol. 2021 11; 39(11):785.e1-785.e10. PMID: 33934965.
    Citations:    Fields:    Translation:Humans
  17. Golijanin B, Gershman B, De Souza A, Kott O, Carneiro BA, Mega A, Golijanin DJ, Amin A. p53 Expression, Programmed Death Ligand 1, and Risk Factors in Urinary Tract Small Cell Carcinoma. Front Oncol. 2021; 11:651754. PMID: 33968753.
    Citations:    
  18. Rodrigues Pessoa R, Mueller AC, Boxley P, Flaig TW, Piper C, Konety B, Yu JB, Gershman B, Kukreja J, Kim SP. Systematic review and meta-analysis of radiation therapy for high-risk non-muscle invasive bladder cancer. Urol Oncol. 2021 11; 39(11):786.e1-786.e8. PMID: 33846085.
    Citations:    Fields:    Translation:Humans
  19. Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 12; 39(12):832.e9-832.e15. PMID: 33820697.
    Citations:    Fields:    Translation:Humans
  20. Nguyen DD, Reitblat CR, Andino JJ, Couture F, Sui W, Cone EB, Gershman B, Haleblian GE, Kathrins MN, Korets R, Kraft KH, Perrotte P, Scarpato KR, Singla A, Lee JY, Bhojani N. Virtual "matchmaking" without visiting electives: Overview of the early U.S. experience and potential applications to the 2021 Canadian urology match. Can Urol Assoc J. 2021 Apr; 15(4):141-143. PMID: 33007185.
    Citations: 3     
  21. Shantharam G, Amin A, Pereira J, Kott O, Mueller-Leonhard C, Mega A, Golijanin D, Gershman B. Intravesical docetaxel for high-risk non-muscle invasive bladder cancer after Bacillus Calmette-Guérin failure. Curr Urol. 2021 Mar; 15(1):33-38. PMID: 34084119; PMCID: PMC8137085.
    Citations:    
  22. Gershman B, Boorjian SA. When Less Is More: The Comparative Effectiveness of Partial Versus Radical Nephrectomy. Eur Urol. 2021 06; 79(6):781-782. PMID: 33773872.
    Citations: 1     Fields:    Translation:Humans
  23. Unadkat P, Fleishman A, Olumi AF, Wagner A, Chang P, Kim SP, Korets R, Gershman B. Contemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancer. Urology. 2021 07; 153:221-227. PMID: 33636210.
    Citations: 2     Fields:    Translation:Humans
  24. Reitblat C, Bellmunt J, Gershman B. Management of Clinically Regional Node-Positive Urothelial Carcinoma of the Bladder. Curr Oncol Rep. 2021 02 09; 23(2):24. PMID: 33559760.
    Citations:    Fields:    Translation:Humans
  25. Chandrasekar T, Boorjian SA, Capitanio U, Gershman B, Mir MC, Kutikov A. Collaborative Review: Factors Influencing Treatment Decisions for Patients with a Localized Solid Renal Mass. Eur Urol. 2021 11; 80(5):575-588. PMID: 33558091.
    Citations: 10     Fields:    Translation:Humans
  26. Reitblat C, Bain PA, Porter ME, Bernstein DN, Feeley TW, Graefen M, Iyer S, Resnick MJ, Stimson CJ, Trinh QD, Gershman B. Value-Based Healthcare in Urology: A Collaborative Review. Eur Urol. 2021 05; 79(5):571-585. PMID: 33413970.
    Citations: 7     Fields:    Translation:Humans
  27. Puneet K, Tilburt JC, Volk RJ, Bennett CL, Qureshi Z, Gershman B, Sedlacek HM, Kim SP. Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national survey. Eur J Cancer Care (Engl). 2021 Jan; 30(1):e13301. PMID: 33112008.
    Citations:    Fields:    Translation:Humans
  28. Unadkat P, Olumi AF, Gershman B. The Role of Lymphadenectomy in Patients with Advanced Renal Cell Carcinoma. Urol Clin North Am. 2020 Aug; 47(3):371-377. PMID: 32600538.
    Citations: 1     Fields:    Translation:Humans
  29. Bacic J, Gershman B. AUTHOR REPLY. Urology. 2020 06; 140:106. PMID: 32456856.
    Citations:    Fields:    
  30. Bacic J, Liu T, Thompson RH, Boorjian SA, Leibovich BC, Golijanin D, Gershman B. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma. Urology. 2020 06; 140:98-106. PMID: 32142726; PMCID: PMC7255934.
    Citations: 3     Fields:    Translation:Humans
  31. Morrison JC, Gershman B, Konety B, Cost N, Kim SP. Centralization of Health Care to Facilitate Greater Use of Nephron-Sparing Surgery for Localized Renal Tumors: Identifying Appropriate Health Care Delivery. Ann Surg Oncol. 2020 Jun; 27(6):1735-1736. PMID: 31974706.
    Citations:    Fields:    Translation:Humans
  32. Kott O, Linsley D, Amin A, Karagounis A, Jeffers C, Golijanin D, Serre T, Gershman B. Development of a Deep Learning Algorithm for the Histopathologic Diagnosis and Gleason Grading of Prostate Cancer Biopsies: A Pilot Study. Eur Urol Focus. 2021 03; 7(2):347-351. PMID: 31767543; PMCID: PMC7242119.
    Citations: 6     Fields:    Translation:Humans
  33. Al-Alao O, Mueller-Leonhard C, Kim SP, Amin A, Tucci C, Kott O, Mega A, Golijanin D, Gershman B. Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model. Urol Oncol. 2020 03; 38(3):76.e19-76.e28. PMID: 31590968.
    Citations: 1     Fields:    Translation:Humans
  34. Golijanin B, Pereira J, Mueller-Leonhard C, Golijanin D, Amin A, Mega A, Boorjian SA, Thompson RH, Leibovich BC, Gershman B. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013. Urol Oncol. 2019 12; 37(12):932-940. PMID: 31570248.
    Citations: 1     Fields:    Translation:Humans
  35. Linder BJ, Gershman B, Bews KA, Glasgow AE, Occhino JA. A National Contemporary Analysis of Perioperative Outcomes for Vaginal Vault Prolapse: Minimally Invasive Sacrocolpopexy Versus Nonmesh Vaginal Surgery. Female Pelvic Med Reconstr Surg. 2019 Sep/Oct; 25(5):342-346. PMID: 30628947.
    Citations:    Fields:    Translation:Humans
  36. Pelcovits A, Mueller-Leonhard C, Mega A, Amin A, Kim SP, Golijanin D, Gershman B. Outcomes of upper tract urothelial carcinoma with isolated lymph node involvement following surgical resection: implications for multi-modal management. World J Urol. 2020 May; 38(5):1243-1252. PMID: 31388818.
    Citations: 4     Fields:    Translation:Humans
  37. Kim SP, Karnes RJ, Mwangi R, Van Houten H, Gross CP, Gershman B, Leapman MS, Shah ND. Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance Database. Eur Urol Focus. 2021 01; 7(1):86-94. PMID: 31047904; PMCID: PMC6819215.
    Citations: 5     Fields:    Translation:Humans
  38. Gershman B, Leibovich BC, Kim SP. Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass. Eur Urol Focus. 2019 Nov; 5(6):970-972. PMID: 30777722.
    Citations: 2     Fields:    Translation:Humans
  39. Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP. A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer. World J Urol. 2019 Oct; 37(10):2099-2108. PMID: 30671637.
    Citations: 2     Fields:    Translation:Humans
  40. Brito J, Golijanin B, Kott O, Moshnikova A, Mueller-Leonhard C, Gershman B, Andreev OA, Reshetnyak YK, Amin A, Golijanin D. Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel pH Low Insertion Peptide (Variant 3), a Molecular Imaging Probe. Urology. 2020 05; 139:134-140. PMID: 30659902; PMCID: PMC8882055.
    Citations: 8     Fields:    Translation:Humans
  41. Pereira JF, Pareek G, Mueller-Leonhard C, Zhang Z, Amin A, Mega A, Tucci C, Golijanin D, Gershman B. The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement. Urology. 2019 03; 125:131-137. PMID: 30366045.
    Citations: 8     Fields:    Translation:Humans
  42. Gershman B, Bukavina L, Chen Z, Konety B, Schumache F, Li L, Kutikov A, Smaldone M, Abouassaly R, Kim SP. The Association of Robot-assisted Versus Pure Laparoscopic Radical Nephrectomy with Perioperative Outcomes and Hospital Costs. Eur Urol Focus. 2020 03 15; 6(2):305-312. PMID: 30361146.
    Citations: 6     Fields:    Translation:Humans
  43. Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. Eur Urol. 2018 12; 74(6):825-832. PMID: 30262341.
    Citations: 18     Fields:    Translation:Humans
  44. Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. Urol Oncol. 2018 11; 36(11):499.e1-499.e7. PMID: 30228096.
    Citations: 4     Fields:    Translation:Humans
  45. Brito J, Pereira J, Moreira DM, Pareek G, Tucci C, Guo R, Zhang Z, Amin A, Mega A, Renzulli J, Golijanin D, Gershman B. The association of lymph node dissection with 30-day perioperative morbidity among men undergoing minimally invasive radical prostatectomy: analysis of the National Surgical Quality Improvement Program (NSQIP). Prostate Cancer Prostatic Dis. 2018 06; 21(2):245-251. PMID: 29858588.
    Citations: 2     Fields:    Translation:Humans
  46. Gershman B, Guo DP, Dahabreh IJ. Using observational data for personalized medicine when clinical trial evidence is limited. Fertil Steril. 2018 06; 109(6):946-951. PMID: 29935652.
    Citations: 4     Fields:    Translation:Humans
  47. Linder BJ, Occhino JA, Habermann EB, Glasgow AE, Bews KA, Gershman B. A National Contemporary Analysis of Perioperative Outcomes of Open versus Minimally Invasive Sacrocolpopexy. J Urol. 2018 10; 200(4):862-867. PMID: 29630983.
    Citations: 8     Fields:    Translation:Humans
  48. Bhindi B, Wallis CJD, Boorjian SA, Thompson RH, Farrell A, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. BJU Int. 2018 05; 121(5):684-698. PMID: 29319926.
    Citations: 24     Fields:    Translation:Humans
  49. Pereira J, Renzulli J, Pareek G, Moreira D, Guo R, Zhang Z, Amin A, Mega A, Golijanin D, Gershman B. Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy: A Contemporary Analysis of the National Surgical Quality Improvement Program. J Endourol. 2018 02; 32(2):116-123. PMID: 29121786; PMCID: PMC5824659.
    Citations: 7     Fields:    Translation:Humans
  50. Gershman B, Thompson RH, Boorjian SA, Larcher A, Capitanio U, Montorsi F, Carenzi C, Bertini R, Briganti A, Lohse CM, Cheville JC, Leibovich BC. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis. J Urol. 2018 05; 199(5):1143-1148. PMID: 29225056.
    Citations: 13     Fields:    Translation:Humans
  51. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2018 Mar; 73(3):469-475. PMID: 29132713.
    Citations: 2     Fields:    
  52. Brito J, Gershman B. The role of lymph node dissection in the contemporary management of renal cell carcinoma: A critical appraisal of the evidence. Urol Oncol. 2017 11; 35(11):623-626. PMID: 28712789.
    Citations: 1     Fields:    Translation:Humans
  53. Haddad AQ, Hutchinson R, Wood EL, Miranda G, Gershman B, Messer J, Svatek R, Black PC, Boorjian SA, Shah J, Daneshmand S, Lotan Y. Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional Study. Clin Genitourin Cancer. 2017 12; 15(6):689-695.e2. PMID: 28558988.
    Citations: 5     Fields:    Translation:Humans
  54. Gershman B, Meier SK, Jeffery MM, Moreira DM, Tollefson MK, Kim SP, Karnes RJ, Shah ND. Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of Care. J Urol. 2017 07; 198(1):92-99. PMID: 28153509.
    Citations: 14     Fields:    Translation:Humans
  55. Gershman B, Van Houten HK, Herrin J, Moreira DM, Kim SP, Shah ND, Karnes RJ. Corrigendum re: "Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications" [Eur Urol 2017;71:55-65]. Eur Urol. 2017 05; 71(5):e160. PMID: 28118942.
    Citations: 1     Fields:    
  56. Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Eur Urol. 2017 08; 72(2):300-306. PMID: 28094055.
    Citations: 25     Fields:    Translation:Humans
  57. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Tollefson MK, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol. 2017 04; 71(4):560-567. PMID: 27671144.
    Citations: 18     Fields:    Translation:Humans
  58. Gershman B, Thompson RH, Moreira DM, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis. J Urol. 2017 03; 197(3 Pt 1):574-579. PMID: 27663461.
    Citations: 11     Fields:    Translation:Humans
  59. Gershman B, Boorjian SA. Primum Non Nocere: Critically Assessing the Morbidity of Prostate Biopsy. Eur Urol. 2017 03; 71(3):366-367. PMID: 27614695.
    Citations: 1     Fields:    Translation:Humans
  60. Zaid HB, Parker WP, Safdar NS, Gershman B, Erwin PJ, Murad MH, Boorjian SA, Costello BA, Thompson RH, Leibovich BC. Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Urol. 2017 01; 197(1):44-49. PMID: 27473875.
    Citations: 25     Fields:    Translation:Humans
  61. Gershman B, Van Houten HK, Herrin J, Moreira DM, Kim SP, Shah ND, Karnes RJ. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications. Eur Urol. 2017 01; 71(1):55-65. PMID: 26995328.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  62. Moreira DM, Gershman B, Lohse CM, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016 Oct; 34(10):1465-72. PMID: 26914818.
    Citations: 13     Fields:    Translation:Humans
  63. Gershman B, Takahashi N, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model. BJU Int. 2016 Nov; 118(5):742-749. PMID: 26800148.
    Citations: 10     Fields:    Translation:Humans
  64. Gershman B, Leibovich BC. Assessing the Evidence for the Surgical Management of Renal Cell Carcinoma with Venous Tumor Thrombus: Room to Grow. Eur Urol. 2016 08; 70(2):281-2. PMID: 26755340.
    Citations: 2     Fields:    Translation:HumansCells
  65. Bernard B, Gershman B, Karnes RJ, Sweeney CJ, Vapiwala N. Approach to Oligometastatic Prostate Cancer. Am Soc Clin Oncol Educ Book. 2016; 35:119-29. PMID: 27249693.
    Citations: 9     Fields:    Translation:Humans
  66. Westerman ME, Gershman B, Karnes RJ, Thompson RH, Rangel L, Boorjian SA. Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy. World J Urol. 2016 Aug; 34(8):1115-22. PMID: 26658661.
    Citations: 6     Fields:    Translation:Humans
  67. Moreira DM, Friedlander JI, Hartman C, Gershman B, Smith AD, Okeke Z. Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition. Urolithiasis. 2016 Aug; 44(4):319-25. PMID: 26573808.
    Citations: 2     Fields:    Translation:Humans
  68. Chew BH, Flannigan R, Kurtz M, Gershman B, Arsovska O, Paterson RF, Eisner BH, Lange D. A Single Dose of Intraoperative Antibiotics Is Sufficient to Prevent Urinary Tract Infection During Ureteroscopy. J Endourol. 2016 Jan; 30(1):63-8. PMID: 26413885.
    Citations: 5     Fields:    Translation:Humans
  69. Moreira DM, Gershman B, Rangel LJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Gettman MT, Karnes RJ. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU Int. 2016 Sep; 118(3):379-83. PMID: 26305996.
    Citations: 1     Fields:    Translation:Humans
  70. Gershman B, Boorjian SA, Hautmann RE. Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know? Bladder Cancer. 2015 Sep 05; 2(1):1-14. PMID: 27376120; PMCID: PMC4927848.
    Citations: 2     
  71. Gershman B, Karnes RJ. Re: comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. Eur Urol. 2015 Sep; 68(3):536-7. PMID: 26282353.
    Citations: 1     Fields:    Translation:Humans
  72. Gershman B, Moreira DM, Tollefson MK, Frank I, Cheville JC, Thapa P, Tarrell RF, Thompson RH, Boorjian SA. The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. Urol Oncol. 2016 Jan; 34(1):4.e1-9. PMID: 26329815.
    Citations: 7     Fields:    Translation:Humans
  73. Moreira DM, Gershman B, Thompson RH, Okuno SH, Robinson SI, Leibovich BC, Boorjian SA. Clinicopathologic characteristics and survival for adult renal sarcoma: A population-based study. Urol Oncol. 2015 Dec; 33(12):505.e15-20. PMID: 26321056.
    Citations: 4     Fields:    Translation:Humans
  74. Gershman B, Psutka SP, McGovern FJ, Dahl DM, Tabatabaei S, Gettman MT, Frank I, Carlson RE, Rangel LJ, Barry MJ, Blute ML, Karnes RJ. Patient-reported Functional Outcomes Following Open, Laparoscopic, and Robotic Assisted Radical Prostatectomy Performed by High-volume Surgeons at High-volume Hospitals. Eur Urol Focus. 2016 Jun; 2(2):172-179. PMID: 28723533.
    Citations: 10     Fields:    
  75. Gershman B, Karnes RJ. Screening for Prostate Cancer: Current Status and Future Directions. Eur Urol Focus. 2015 Sep; 1(2):147-148. PMID: 28723425.
    Citations:    Fields:    
  76. Gershman B, Moreira DM, Boorjian SA, Lohse CM, Cheville JC, Costello BA, Leibovich BC, Thompson RH. Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. Eur Urol. 2016 Jan; 69(1):84-91. PMID: 26044802.
    Citations: 19     Fields:    Translation:Humans
  77. Gershman B, Eisenberg MS, Thompson RH, Frank I, Kaushik D, Tarrell R, Thapa P, Boorjian SA. Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a. Int J Urol. 2015 Jul; 22(7):651-6. PMID: 25881721.
    Citations: 8     Fields:    Translation:Humans
  78. Barrisford GW, Gershman B, Blute ML. The role of lymphadenectomy in the management of renal cell carcinoma. World J Urol. 2014 Jun; 32(3):643-9. PMID: 24723269.
    Citations: 6     Fields:    Translation:Humans
  79. Gershman B, Eisner BH, Sheth S, Sacco DE. Ureteral stenting and retrograde pyelography in the office: clinical outcomes, cost effectiveness, and time savings. J Endourol. 2013 May; 27(5):662-6. PMID: 23638674.
    Citations:    Fields:    Translation:Humans
  80. Sterious S, Simhan J, Uzzo RG, Gershman B, Li T, Devarajan K, Canter D, Walton J, Fogg R, Ginzburg S, Corcoran A, Smaldone MC, Kutikov A. Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members. J Urol. 2013 Sep; 190(3):992-8. PMID: 23538239.
    Citations: 14     Fields:    Translation:Humans
  81. Gershman B, Shui IM, Stampfer M, Platz EA, Gann PH, Sesso HL, DuPre N, Giovannucci E, Mucci LA. Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer. Eur Urol. 2014 Apr; 65(4):683-9. PMID: 23340241; PMCID: PMC3664134.
    Citations: 15     Fields:    Translation:Humans
  82. Gershman B, Sheth S, Dretler SP, Herrick B, Lang K, Pais VM, Eisner BH. Relationship between glomerular filtration rate and 24-hour urine composition in patients with nephrolithiasis. Urology. 2012 Jul; 80(1):38-42. PMID: 22608801.
    Citations: 12     Fields:    Translation:Humans
  83. Gershman B, Zietman AL, Feldman AS, McDougal WS. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies. Urol Oncol. 2013 Oct; 31(7):1093-7. PMID: 22305626.
    Citations: 14     Fields:    Translation:Humans
  84. Gershman B, Eisner BH. Editorial comment. Urology. 2012 May; 79(5):994-5. PMID: 22309785.
    Citations:    Fields:    Translation:Humans
  85. Gershman B, Eisner BH. Editorial comment. Urology. 2012 Jan; 79(1):92-3; author reply 93-4. PMID: 22202545.
    Citations:    Fields:    Translation:Humans
  86. Gershman B, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL. Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol. 2013 Oct; 31(7):1033-7. PMID: 22206627.
    Citations: 16     Fields:    Translation:Humans
  87. Gershman B, Kulkarni N, Sahani DV, Eisner BH. Causes of renal forniceal rupture. BJU Int. 2011 Dec; 108(11):1909-11; discussion 1912. PMID: 21736690.
    Citations: 37     Fields:    Translation:Humans
  88. Chew BH, Paterson RF, Ferlic EA, Humphreys MR, Gershman B, Eisner BH. Case presentation. J Endourol. 2011 Jul; 25(7):1105-9. PMID: 21711133.
    Citations:    Fields:    Translation:HumansCells
  89. Kutikov A, Vanarsdalen KN, Gershman B, Fossett LK, Guzzo TJ, Wein AJ, Malkowicz SB. Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int. 2008 Sep; 102(6):688-91. PMID: 18384627.
    Citations: 6     Fields:    Translation:Humans
  90. Gershman B, Puig O, Hang L, Peitzsch RM, Tatar M, Garofalo RS. High-resolution dynamics of the transcriptional response to nutrition in Drosophila: a key role for dFOXO. Physiol Genomics. 2007 Mar 14; 29(1):24-34. PMID: 17090700.
    Citations: 85     Fields:    Translation:AnimalsCells
  91. Hwangbo DS, Gershman B, Gersham B, Tu MP, Palmer M, Tatar M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature. 2004 Jun 03; 429(6991):562-6. PMID: 15175753.
    Citations: 419     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Gershman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (226)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.